Chargement en cours...
Effect of pimobendan in patients with chronic heart failure
OBJECTIVE: To assess the effects of a calcium sensitizer, pimobendan, in patients with mild to moderate chronic heart failure. PATIENTS AND METHODS: Pimobendan was administered at a dose of 2.5 mg/day for 12 months to 34 patients with chronic heart failure (New York Heart Association functional clas...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Pulsus Group Inc
2001
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2858999/ https://ncbi.nlm.nih.gov/pubmed/20428258 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|